Safety information on medicines for healthcare professionals sent in August 2008

Printer friendly version (new window)

A list of letters sent to healthcare professionals in August 2008, to inform of new safety information and advice.

Date issued	Product	Safety information
05/08/2008	Revlimid (lenalidomide) (38Kb)	Preclinical data for teratogenicity
21/07/2008 to 08/08/2008	Celance (pergolide) (40Kb)	Fibrotic reactions, including cardiovalvulopathy, associated with chronic use
15/08/2008	Tysabri (natalizumab) (376Kb)	Progressive multifocal leukoencephalopathy

Page last modified: 01 September 2008

Find out about who we are and what we do. Also find out about working for us...

Find out how we regulate medicines (including herbal medicines), devices, tissue engineering, nanotechnology and blood...

Safety alerts, warnings, information and advice. Also how you can report a safety problem...

Information on our advisory committees including their meeting minutes and membership...

Details of our conferences, seminars and learning resources on topics related to our work...

Sign-up for e-mail notifications; report safety problems and links to other online services...

Details of our vast array of publications, many available to view online...

Breaking news and a full archive of our press releases. Also our press contacts and image library...

Give us your views on our consultations and our website. Also how you can make a complaint...